• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用含铝佐剂或不含佐剂疫苗进行肌肉注射和皮下免疫后的炎症反应。

Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines.

作者信息

Kashiwagi Yasuyo, Maeda Mika, Kawashima Hisashi, Nakayama Tetsuo

机构信息

Department of Pediatrics, Tokyo Medical University, Tokyo 160-0023, Japan.

Kitasato Institute for Life Sciences, Laboratory of Viral Infection, Tokyo 108-8641, Japan.

出版信息

Vaccine. 2014 Jun 5;32(27):3393-401. doi: 10.1016/j.vaccine.2014.04.018. Epub 2014 Apr 24.

DOI:10.1016/j.vaccine.2014.04.018
PMID:24768634
Abstract

Aluminum-adjuvanted vaccines are administered through an intramuscular injection (IM) in the US and EU, however, a subcutaneous injection (SC) has been recommended in Japan because of serious muscle contracture previously reported following multiple IMs of antibiotics. Newly introduced adjuvanted vaccines, such as the human papillomavirus (HPV) vaccines, have been recommended through IM. In the present study, currently available vaccines were evaluated through IM in mice. Aluminum-adjuvanted vaccines induced inflammatory nodules at the injection site, which expanded into the intra-muscular space without any muscle degeneration or necrosis, whereas non-adjuvanted vaccines did not. These nodules consisted of polymorph nuclear neutrophils with some eosinophils within the initial 48h, then monocytes/macrophages 1 month later. Inflammatory nodules were observed 6 months after IM, had decreased in size, and were absorbed 12 months after IM, which was earlier than that after SC. Cytokine production was examined in the injected muscular tissues and AS04 adjuvanted HPV induced higher IL-1β, IL-6, KC, MIP-1, and G-CSF levels in muscle tissues than any other vaccine, but similar serum cytokine profiles were observed to those induced by the other vaccines. Currently available vaccines did not induce muscular degeneration or fibrotic scar as observed with muscle contracture caused by multiple IMs of antibiotics in the past.

摘要

在美国和欧盟,铝佐剂疫苗通过肌肉注射(IM)给药,然而,在日本建议皮下注射(SC),因为此前有报道称多次肌肉注射抗生素后会出现严重的肌肉挛缩。新引入的佐剂疫苗,如人乳头瘤病毒(HPV)疫苗,建议通过肌肉注射。在本研究中,对目前可用的疫苗在小鼠中进行了肌肉注射评估。铝佐剂疫苗在注射部位诱导炎性结节,这些结节扩展到肌肉间隙,没有任何肌肉变性或坏死,而非佐剂疫苗则不会。这些结节在最初48小时内由多形核中性粒细胞和一些嗜酸性粒细胞组成,1个月后则由单核细胞/巨噬细胞组成。肌肉注射6个月后观察到炎性结节,其大小减小,肌肉注射12个月后被吸收,这比皮下注射后更早。在注射的肌肉组织中检测细胞因子产生情况,AS04佐剂HPV在肌肉组织中诱导的IL-1β、IL-6、KC、MIP-1和G-CSF水平高于任何其他疫苗,但观察到的血清细胞因子谱与其他疫苗诱导产生的相似。目前可用的疫苗不会像过去多次肌肉注射抗生素导致肌肉挛缩那样引起肌肉变性或纤维化瘢痕。

相似文献

1
Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines.使用含铝佐剂或不含佐剂疫苗进行肌肉注射和皮下免疫后的炎症反应。
Vaccine. 2014 Jun 5;32(27):3393-401. doi: 10.1016/j.vaccine.2014.04.018. Epub 2014 Apr 24.
2
Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant.肌肉内注射铝佐剂后炎症反应的动力学。
Vaccine. 2013 Aug 20;31(37):3979-86. doi: 10.1016/j.vaccine.2013.05.107. Epub 2013 Jun 14.
3
Long-term regulation of local cytokine production following immunization in mice.小鼠免疫后局部细胞因子产生的长期调节
Microbiol Immunol. 2018 Feb;62(2):124-131. doi: 10.1111/1348-0421.12566.
4
AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.AS04是一种基于铝盐和Toll样受体4(TLR4)激动剂的佐剂系统,可诱导短暂的局部先天性免疫反应,从而增强适应性免疫。
J Immunol. 2009 Nov 15;183(10):6186-97. doi: 10.4049/jimmunol.0901474. Epub 2009 Oct 28.
5
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.南非 HIV 阳性女性中 HPV-16/18 AS04 佐剂疫苗的安全性和免疫原性:一项部分盲随机安慰剂对照研究。
Vaccine. 2013 Nov 19;31(48):5745-53. doi: 10.1016/j.vaccine.2013.09.032. Epub 2013 Oct 1.
6
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.细菌样颗粒佐以灭活流感抗原经鼻内给药诱导交叉保护性流感特异性抗体应答。
Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.
7
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems.一项关于不同佐剂系统的 2009 年甲型 H1N1 流感灭活单价疫苗的 I 期随机、双盲、对照临床试验。
Vaccine. 2011 Nov 8;29(48):8974-81. doi: 10.1016/j.vaccine.2011.09.040. Epub 2011 Sep 21.
8
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.新型 Matrix-M™ 佐剂具有免疫增强特性,可增强小鼠对流感疫苗的免疫应答。
Vaccine. 2013 Mar 25;31(13):1725-33. doi: 10.1016/j.vaccine.2013.01.039. Epub 2013 Feb 4.
9
Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials.不同抗原和佐剂系统对研究性四价人致癌乳头瘤病毒疫苗免疫原性和安全性的影响:两项随机试验的结果
Vaccine. 2014 Jun 17;32(29):3694-705. doi: 10.1016/j.vaccine.2014.03.040. Epub 2014 Mar 25.
10
Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.最近使用含有 MPL 和 QS-21 的佐剂系统的疫苗的临床经验。
Expert Rev Vaccines. 2011 Apr;10(4):471-86. doi: 10.1586/erv.11.29.

引用本文的文献

1
Safety assessments of recombinant DTaP vaccines developed in South Korea.韩国研发的重组白百破疫苗的安全性评估。
Clin Exp Vaccine Res. 2024 Apr;13(2):155-165. doi: 10.7774/cevr.2024.13.2.155. Epub 2024 Apr 30.
2
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections.盟友、对手还是仲裁者?嗜酸性粒细胞在呼吸道病毒疫苗接种及其随后突破性感染中的上下文相关作用。
J Leukoc Biol. 2024 Jul 25;116(2):224-243. doi: 10.1093/jleuko/qiae010.
3
Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028).
15 价肺炎球菌结合疫苗在日本健康婴儿中的安全性和免疫原性:一项 I 期研究(V114-028)。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2180973. doi: 10.1080/21645515.2023.2180973. Epub 2023 Mar 7.
4
Critical evaluation on roles of macrophagic myofasciitis and aluminum adjuvants in HPV vaccine-induced adverse events.对巨细胞性肌筋膜炎和铝佐剂在 HPV 疫苗引起的不良事件中的作用的批判性评估。
Cancer Sci. 2023 Apr;114(4):1218-1228. doi: 10.1111/cas.15714. Epub 2023 Feb 8.
5
Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination.人乳头瘤病毒(HPV)疫苗接种后发生的青少年膜性肾病
Vaccines (Basel). 2022 Sep 1;10(9):1442. doi: 10.3390/vaccines10091442.
6
Appropriate Needle Length Determined by Ultrasonic Echography for Intramuscular Injection in Japanese Elderly over 50 Years.超声心动图确定50岁以上日本老年人肌肉注射的合适针头长度
Healthcare (Basel). 2022 Apr 25;10(5):800. doi: 10.3390/healthcare10050800.
7
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.接种疫苗后与炎症相关的不良反应可能表明免疫反应更强。
Emerg Microbes Infect. 2021 Dec;10(1):365-375. doi: 10.1080/22221751.2021.1891002.
8
Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction.肺内接种 δ-菊糖佐剂可刺激非极化趋化信号和多种细胞相互作用。
Mucosal Immunol. 2021 May;14(3):762-773. doi: 10.1038/s41385-021-00379-6. Epub 2021 Feb 4.
9
Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants.两种含有新城疫LaSota株和禽流感H9N2西德拉普分离株并使用不同油佐剂配制的二价疫苗的比较安全性和有效性。
Vet World. 2020 Nov;13(11):2493-2501. doi: 10.14202/vetworld.2020.2493-2501. Epub 2020 Nov 24.
10
Unequivocal imaging of aluminium in human cells and tissues by an improved method using morin.使用桑色素改进方法对人体细胞和组织中的铝进行明确成像。
Histochem Cell Biol. 2019 Dec;152(6):453-463. doi: 10.1007/s00418-019-01809-0. Epub 2019 Aug 28.